Cyclotron production of 43Sc for PET imaging

EJNMMI Physics - 2015
Rafał Walczak1, Seweryn Krajewski2, Katarzyna Szkliniarz3, Mateusz Sitarz4, K. Abbas5, J. Choiński4, Andrzej Jakubowski4, J. Jastrzębski4, Agnieszka Majkowska1, Federica Simonelli6, A. Stolarz4, A. Trzcińska4, W. Zipper3, Aleksander Bilewicz7
1Institute of Nuclear Chemistry and Technology, Dorodna 16, 03-195 Warsaw, Poland
2Synektik S.A., Research and Development Center, Warsaw, Poland
3Department of Nuclear Physics, University of Silesia, Katowice, Poland
4Heavy Ion Laboratory, University of Warsaw, Warsaw, Poland
5Nuclear Security Unit, Joint Research Centre, Institute for Transuranium Elements, European Commission, Ispra, Italy
6Nuclear Decommissioning Unit, Joint Research Centre, Ispra Site Management Directorate, European Commission, Ispra, Italy
7Institute of Nuclear Chemistry and Technology, Dorodna 16, 03–195 Warsaw, Poland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Maecke HR, Reubi JC. Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment. J Nucl Med. 2011;52:841–4.

Pool SE, Krenning EP, Eric P, Koning GA, Van Eijck CHJ, Casper HJ, et al. Preclinical and clinical studies of peptide receptor radionuclide therapy. Sem Nucl Med. 2010;40:209–18.

Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, et al. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imag. 2007;34:982–93.

Roesch F, Riss PJ. The renaissance of the 68Ge/68Ga radionuclide generator initiates new developments in 68Ga radiopharmaceutical chemistry. Curr Top Med Chem. 2010;10:1633–8.

Anderson CJ, Ferdani R. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biother Radiopharm. 2009;24:379–93.

Pruszyski M, Loktionova N, Filosofov D, Roesch F. Post-elution processing of 44Ti/44Scgenerator derived 44Sc for clinical application. Appl Radiat Isot. 2010;68:1636–41.

Rösch F. Scandium-44: benefits of a long-lived PET radionuclide available from the 44Ti/44Sc generator system. Curr Radiopharm. 2012;5:187–201.

Filosofov DV, Loktionova NS, Roesch F. A 44Ti/44Sc radionuclide generator for potential nuclear-medical application of 44Sc-based PET-radiopharmaceuticals. Radiochim Acta. 2010;98:149–56.

Krajewski S, Cydzik I, Abbas K, Bulgheroni A, Simonelli F, Holzwarth U, et al. Cyclotron production of 44Sc for clinical application. Radiochim Acta. 2013;101:333–8.

Müller C, Bunka M, Reber J, Fischer C, Zhernosekov K, Türler A, et al. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β− emitters: in-vitro and in-vivo study of a 44Sc-DOTA-folate conjugate. J Nucl Med. 2013;54:2168–74.

Severin G, Engle J, Valdovinos H, Barnhart T, Nickles R. Cyclotron produced 44gSc from natural calcium. Appl Radiat Isot. 2012;70:1526–30.

Duchemin C, Guertin A, Haddad F, Michel N, Metivier V. Production of scandium-44m and scandium-44g with deuterons on calcium-44: cross section measurements and production yield calculations. Phys Med Biol. 2015;60:6847-6864.

Haddad F, Ferrer L, Guertin A, Carlier T, Michel N, Barbet J, et al. ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine. Eur J Nucl Med Mol Imaging 2008;35:1377–87.

Huclier-Markai S, Kerdjoudj R, Alliot C, Bonraisin AC, Michel N, Haddad F, et al. Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with 44m/44Sc and experimental evidence of the feasibility of an in vivo PET generator. Nucl Med Biol. 2014;41:e36–43 [Suppl.].

Majkowska-Pilip A, Bilewicz A. Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals. J Inorg Biochem. 2011;105:313–20.

Bartoś B, Majkowska A, Kasperek A, Krajewski S, Bilewicz A. New separation method of no-carrier-added 47Sc from titanium targets. Radiochim Acta. 2012;100:457–62.

Mausner LF, Kolsky KL, Joshi V, Srivastava SC. Radionuclide development at BNL for nuclear medicine therapy. Appl Radiat Isot. 1998;49:285–94.

Kolsky KL, Joshi V, Mausner LF, Srivastava SC. Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy. Appl Radiat Isot. 1998;49:1541–9.

Majkowska A, Neves M, Antunes I, Bilewicz A. Complexes of low energy beta emitters 47Sc and 177Lu with zoledronic acid for bone pain therapy. Appl Radiat Isot. 2009;67:11–3.

Howard AJ, Jensen HB, Rios M, Fowler WA, Zimmerman BA. Measurement and theoretical analysis of some reaction rates of interest in silicon burning. Astroph J. 1974;188:131.

Browne E, Firestone RB. In: Shirley VS, editor. Table of radioactive isotopes. USA: John Wiley & Son; 1986.

Valdovinos HF, Hernandez R, Barnhart TE, Graves S, Cai W, Nickles RJ. Separation of cyclotron-produced 44Sc from a natural calcium target using a dipentyl pentylphosphonate functionalize dextraction resin. Appl Radiat Isot. 2015;95:23–9.

Levkovskij VN. Activation cross section for medium mass nuclei (A = 40–100) by medium energy protons and alpha particles (E = 10–50 MeV). Moscow: USSR; 1991.

van der Meulen NP, Bunka M, Domnanich KA, Müller C, Haller S, Vermeulen C, et al. Cyclotron production of 44Sc: from bench to bedside. Nucl Med Biol. 2015;42:745–51.

Martell A, Smith R, Motekaitis R. NIST critically selected stability constants of metal complexes database. 2004. http://www.nist.gov/srd/nist46.cfm .

Scott PJ, Hockley BG, Kung HF, Manchanda R, Zhang W, Kilbourn MR. Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography. Appl Radiat Isot. 2009;67:88–94.

Thông tin
Thông tin xuất bản

EJNMMI Physics

Thông tin tác giả